Regulatory Q&A Forum

When medical device manufacturers are forecasting their regulatory compliance budgets for 2026, simply asking for a quote for "PRRC as a Service" may not capture the full financial picture. To build a...

While it is not possible to provide a specific cost for a "Person Responsible for Regulatory Compliance (PRRC) as a Service" contract for 2026, manufacturers can effectively budget by understanding th...

For medical device sponsors planning a premarket submission in the 2025-2026 timeframe, particularly for software-based or connected devices, what are the key strategic considerations for building a r...

With the European Chemicals Agency (ECHA) developing a proposal for broad restrictions on per- and polyfluoroalkyl substances (PFAS) under the REACH regulation, how should non-EU medical device manufa...

For non-EU manufacturers of medical devices, such as wearable cardiac monitors or diagnostic software (SaMD), planning market entry or continued distribution in France, the upcoming 2026 VAT reforms p...

For a novel Class II in vitro diagnostic (IVD) test system, such as a prognostic test for liver disease assessment (governed by regulations like 21 CFR 862.1622) or an acute kidney injury test system ...

With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), foreign cosmetic facilities are now required to designate a U.S. Agent to serve as their official point of contact wit...

With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), foreign cosmetic facilities must now designate a U.S. Agent for FDA communications. While this is a mandatory requirem...

When budgeting for 2026, how can medical device manufacturers accurately forecast the cost of engaging an external "PRRC as a Service" provider under the EU Medical Device Regulation (MDR)? Beyond a s...

While it is not possible to provide specific pricing for PRRC (Person Responsible for Regulatory Compliance) as a Service for 2026, manufacturers can anticipate costs by understanding the key factors ...

When developing a connected medical device, such as a Class II integrated continuous glucose monitoring (iCGM) system intended for submission in the 2025-2026 timeframe, what key regulatory considerat...

For non-EU manufacturers planning for market access in 2026, how can a comprehensive and realistic budget for an EU REACH Only Representative (OR) be developed that moves beyond simple service fees an...

For manufacturers of in vitro diagnostic (IVD) components, what are the key regulatory distinctions between marketing Analyte Specific Reagents (ASRs) and general-purpose laboratory equipment versus p...

For Class II medical devices, particularly in the diagnostics space, how do Special Controls function as a regulatory requirement beyond the baseline General Controls? While General Controls apply to ...

For a medical device manufacturer placing electronic devices on the market in the EU or other regions with Extended Producer Responsibility (EPR) regulations, how can they develop a robust framework f...

For developers of novel in vitro diagnostic (IVD) platforms, particularly in areas like pharmacogenetics or clinical chemistry, what are the critical regulatory delineators and evidence expectations t...

When planning for regulatory compliance budgets for 2026, many medical device manufacturers, particularly small to medium-sized enterprises, must account for the cost of outsourcing key roles. For com...

For medical device manufacturers preparing their long-term compliance strategy under the EU MDR, selecting an external Person Responsible for Regulatory Compliance (PRRC) is a critical decision. Beyon...

While specific costs for an outsourced Person Responsible for Regulatory Compliance (PRRC) service vary, manufacturers can evaluate potential expenses by understanding the key factors that influence p...

For medical device manufacturers, navigating the global regulatory landscape is becoming increasingly complex, extending beyond traditional premarket submission pathways like the FDA 510(k) or EU MDR....